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Transcriptional regulatory program in wild-type
and retinoblastoma gene-deficient mouse
embryonic fibroblasts during adipocyte
differentiation
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Juliane G Bogner-Strauss4, Stefan R Bornstein1, Jacob B Hansen5, Lise Madsen6,7, Karsten Kristiansen6,
Zlatko Trajanoski2 and Hubert Hackl2*
Abstract
Background: Although many molecular regulators of adipogenesis have been identified a comprehensive
catalogue of components is still missing. Recent studies showed that the retinoblastoma protein (pRb) was
expressed in the cell cycle and late cellular differentiation phase during adipogenesis. To investigate this dual role
of pRb in the early and late stages of adipogenesis we used microarrays to perform a comprehensive systems-level
analysis of the common transcriptional program of the classic 3T3-L1 preadipocyte cell line, wild-type mouse
embryonic fibroblasts (MEFs), and retinoblastoma gene-deficient MEFs (Rb-/- MEFs).
Findings: Comparative analysis of the expression profiles of 3T3-L1 cells and wild-type MEFs revealed genes
involved specifically in early regulation of the adipocyte differentiation as well as secreted factors and signaling
molecules regulating the later phase of differentiation. In an attempt to identify transcription factors regulating
adipogenesis, bioinformatics analysis of the promoters of coordinately and highly expressed genes was performed.
We were able to identify a number of high-confidence target genes for follow-up experimental studies.
Additionally, combination of experimental data and computational analyses pinpointed a feedback-loop between
Pparg and Foxo1.
To analyze the effects of the retinoblastoma protein at the transcriptional level we chose a perturbated system
(Rb-/- MEFs) for comparison to the transcriptional program of wild-type MEFs. Gene ontology analysis of 64
deregulated genes showed that the Rb-/- MEF model exhibits a brown(-like) adipocyte phenotype. Additionally,
the analysis results indicate a different or additional role for pRb family member involvement in the lineage
commitment.
Conclusion: In this study a number of commonly modulated genes during adipogenesis in 3T3-L1 cells and MEFs,
potential transcriptional regulation mechanisms, and differentially regulated targets during adipocyte differentiation
of Rb-/- MEFs could be identified. These data and the analysis provide a starting point for further experimental
studies to identify target genes for pharmacological intervention and ultimately remodeling of white adipose tissue
into brown adipose tissue.
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Introduction
Evidence accumulating during the past decades has
convincingly revealed that adipocytes and adipose tissue
are not only acting as a storage depot for fat, but are
also actively involved in regulating whole body energy
balance, and much attention has been dedicated to deci-
pher molecular events and to identify factors involved in
fat cell development. Although many molecular regula-
tors have been identified, a comprehensive catalogue of
components regulating adipogenesis is still missing.
Therefore, a number of expression profiling studies
using microarrays have been performed to monitor glo-
bal gene expression profiles during in vitro adipocyte
differentiation of several cell models [1].
Recently, we have studied global gene expression of
3T3-L1 cells during adipogenesis and identifying mole-
cular mechanisms, biological processes, key enzymes,
including many characterized and uncharacterized tran-
scriptional regulators, thereby providing a gene expres-
sion atlas using functional annotation [2]. We showed
that the mitotic clonal expansion phase plays an impor-
tant role during adipocyte differentiation in the studied
mouse cell model. One group of proteins - the pocket
proteins including the retinoblastoma protein (pRb) and
other members (p130, p107) - was expressed during
both, the cell cycle phase and late cellular differentia-
tion. This dual role of pRb in the early and late stages
of adipogenesis was also described in other studies [3-6].
Pathways regulated by the retinoblastoma gene/protein
might therefore be interesting novel targets in the com-
bat to curb or to treat obesity and associated disorders.
Several studies on mechanisms and interactions have
elucidated how pRb - the product of the Rb1 gene - fulfills
its functions. pRb is phosphorylated by cyclin-dependent
kinases thereby regulating E2F activity [5]. Other mechan-
isms include co-factor activity for none-E2F transcription
factors, recruitment of chromatin remodeling complexes
(including HDACs) and action as a non-chromatin asso-
ciated protein adaptor [4,6,7]. The first evidence that
pocket proteins are involved in adipocyte differentiation
emerged by showing interactions with the C/EBP tran-
scription factors [8,9]. It was shown that the ability of the
C-terminally truncated large T antigen (TAg) to inhibit
differentiation of white preadipocyte cell lines is depen-
dent on the ability to sequester pRb family members [10].
Further studies showed that pRb and p107/p130 may have
opposite effects on adipocyte differentiation [11,12].
Rb-/- mouse embryonic fibroblasts (MEFs) are unable
to undergo adipose conversion using standard adi-
pogenic inducers [8,13,14]. It was suggested that the
underlying mechanism did not directly mirror cell cycle-
related aspects of pRb function, as Rb-/- cells enter and
exit mitotic clonal expansion with the same kinetics as
wild-type cells [13]. Further it was shown that pRb is
required for preadipocyte differentiation in vivo [12,15]
and functions as a molecular switch determining white
versus brown(-like) adipocyte differentiation [14,16].
Of note, adipose tissue-specific inactivation of Rb
prevents [15] and haploinsufficiency of Rb attenuates
diet induced obesity and insulin resistance [17]. pRb
might also be involved in the lineage commitment to
osteogenic or adipogenic differentiation of mesenchymal
stem cells [18].
Thus, given the accumulated evidence of the involve-
ment of pRb in adipogenesis we initiated a large scale
gene expression study to elucidate its role during adipo-
genic differentiation. We first performed microarray
gene expression analysis of wild-type mouse embryonic
fibroblasts (MEFs) undergoing adipogenesis and com-
pared these expression data with microarray gene
expression data from 3T3-L1 cell adipogenesis to iden-
tify a transcriptional program common between the two
cell models. Additionally, bioinformatics analyses were
carried on the promoters of highly expressed genes to
identify potential transcription factor binding sites and
to generate hypotheses on transcription factor binding.
To analyze the effects of the retinoblastoma protein at
the transcriptional level we chose a perturbated system
(Rb-/- MEFs) for comparison to the transcriptional
program of wild-type MEFs.
Results and Discussion
Common transcriptional program of adipocyte
differentiation in MEFs and 3T3-L1 cells
To compare transcriptional regulation during adipocyte
differentiation of the established 3T3-L1 cell line and
mouse embryonic fibroblasts (MEFs), gene expression in
MEFs was studied in three independent experiments
with whole genome cDNA microarrays (>27k elements)
using seven time points (d0, d1, d2, d3, d4, d6, d10)
after hormonal induction in relation to expression levels
at the preconfluent stage (similar to the generation of
data from the previous 3T3-L1 study [2]) (Additional
file 1). We validated the microarray data from MEFs by
quantitative reverse transcription polymerase chain reac-
tion (qPCR) analysis of the first differentiation experi-
ment (see Figure S1 in Additional file 2) with six genes
at several time points. Applying linear regression of the
resulting 18 data points showed a coefficient of determi-
nation (R2) of 0.92 (Pearson correlation coefficient
r = 0.96), which represented good agreement between
microarray and qPCR results. Replicate results were also
in good concordance with log2-fold changes averaged
over the three independent differentiation experiments.
Differentially expressed genes with similar combined
expression profiles of the 3T3-L1 and MEF cells were
grouped into 6 clusters by k-means clustering (Figure 1
and Additional file 1). Proficient quality of clustering
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Figure 1 Gene expression levels (log2-fold change) of genes from different time points during adipocyte differentiation in 3T3-L1 and
MEF cells. (A) Compact heatmaps from k-means clustering. (B) Line drawing centroid view (mean +/- SD). (C) Three-dimensional visualization
of Principal Component Analysis (PCA) (color coding according k-means clustering) demonstrates cluster separation. (D) Line drawing for
expression course of each gene individually.
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was evident from different visualizations of the gene
expression levels and separation of clusters using Princi-
pal Component Analysis (PCA) in three-dimensional
view of the first three principal components and color-
coding according to k-means clustering (Figure 1).
Functional assignment of genes within each cluster by
gene ontology analysis revealed a number of noticeable
biological processes regulated at the transcriptional level
(Figure 2). Most significantly overrepresented biological
processes were ‘cell cycle’, ‘cell division’, ‘DNA replica-
tion’, and ‘mitosis’ indicating mainly the involvement of
genes of cluster E and cluster B in cell cycle processes.
Distinct peaks in the expression profiles of these genes
at d1 and d3 showed that MEFs underwent two cycles
of mitotic clonal expansion comparable to the 3T3-L1
cells showing - at the used sampling rate - one peak in
the expression profiles at 24 h [2] which could reflect
the first of two rounds of mitotic clonal expansions
[19,20]. This observation is supported by reported phos-
phorylation events of the pRb in 3T3-L1 cells during
differentiation [3,13] and the cyclin A2 (Ccna2) expres-
sion profile as shown in Additional file 1 and Additional
file 2.
As evident from the gene ontology analysis of genes
in cluster E, significantly overrepresented biological
processes were ‘fatty acid metabolism’, ‘lipid metabo-
lism’, ‘metabolism’, and ‘fatty acid beta-oxidation’. Well
known genes important for the development of the
adipocyte phenotype were combined in cluster F with
increasing expression over time, including transcription
factors and nuclear receptors Pparg, Cebpa, Srebf1,
Xbp1, Thra, Stat1, Nr0b2 (SHP), Nr1d1 (REV-ERB
alpha), Nr3c1 (GR), Foxc1, Foxo1, Zhx1, and Zfp503.
The recently identified gene coding for adipocyte
plasma membrane-associated protein [21] was also
shown to be highly expressed at late stages of adipo-
genesis of MEFs (cluster F).
Highly expressed genes over the differentiation course,
especially at the middle stage of adipogenesis (after
mitotic clonal expansion) could be found in cluster A.
In this group we observed not only transcription factors
like Klf9 [22], and Foxo3a [23] but also secreted factors
(as studied in human [24]) including Apod [25], Ccdc80
[26], Adamts5 [27], Mmp2 [28], and Ptn [29], as well as
enzymes, signaling molecules, and other factors such as
Xdh [30], Enpp2 [31], Rgs2 [32], Txnip [33], Tsc22d3
[34], H6pd [35], Igfbp2 [36], and Igfbp3 [37]. Hence, the
genes in cluster A represent potential novel players in
adipogenesis and are therefore candidates to be studied
in more detail experimentally.
To identify candidates selectively associated with the
MEF cell model, genes upregulated during MEF differ-
entiation which showed marginal changes in 3T3-L1
adipocytes compared to the preconfluent stage of 3T3-
L1 are of major interest (cluster D). Genes in this clus-
ter were overrepresented in the GO terms ‘heart devel-
opment’, ‘negative regulation of cell proliferation’, ‘cell
adhesion’, ‘extra cellular matrix organization and biogen-
esis’, and ‘positive regulation of angiogenesis’. The
expressed transcription factors include Arnt, Arnt2,
Atf5, Ets2, Egr1, Fosl2, JunB, Nfia, Prdm4, Stat2, Stat3,
Tef, and Tcf20 which might be involved specifically in
early regulation of adipocyte differentiation in the pri-
mary cell model as opposed to the already committed
3T3-L1 preadipocytes.
Transcription factors regulating gene expression during
adipocyte differentiation
The terminal development of a fat cell is driven by a
transcriptional cascade governed mainly by Pparg and
Cebpa (as reviewed in [38,39]). The transcriptional
events directing early adipogenic processes, concerted
by molecular events prior to the activation of Pparg and
Cebpa have not been exhaustively studied. Hence, we
asked if there are common regulators of expression of
genes within each cluster, especially those with expres-
sion profiles similar to a transcription factor and its tar-
get genes. To address this question, we calculated
overrepresentation of sequence motifs (response ele-
ments) within a genomic region (including promoter)
from -3 kb to +2 kb relative to transcription start site
(TSS) of those genes (Additional file 3).
From the transcription factors with exclusively overre-
presented binding sites (Figure 3A) in promoters of
genes from cluster F (i.e. genes with increasing expres-
sion towards terminal adipocyte differentiation) only
Foxo1 and the key player in adipogenesis Pparg have
expression profiles in cluster F. It has been previously
shown that Foxo1 can interact with Pparg [40]. Further-
more, Foxo1 can bind to the Pparg promoter region and
suppress Pparg expression [41]. Our analyses suggest
that a feed-back loop from Pparg to Foxo1 might exist.
To provide further evidence we analyzed two datasets of
DNA binding by Pparg identified by chromatin immu-
noprecipitation (ChIP) followed by sequencing [42] or
by microarray analysis [43] during 3T3-L1 adipocyte dif-
ferentiation. Integrative analysis of these datasets and
Pparg binding sites in genomic regions around genes
with expression profile similar to that of Pparg in both
the 3T3-L1 cells and MEFs (cluster F), revealed that
Foxo1 might indeed be regulated by Pparg as indicated
in Figure 3B. Thus, our data, experimental results from
other studies, and further computational analysis pin-
pointed a feed-back loop between Pparg and Foxo1.
We have recently identified 2310001A20Rik (Apmap),
as well as the retrotransposed genes 6530401D17Rik
(Arxes1) and 2900062L11Rik (Arxes2) as Pparg targets
and that they are required for adipogenesis [21,44].
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Figure 2 Gene ontology analysis. Heatmap for overrepresented gene ontology terms for genes in 6 clusters over several time points during
adipocyte differentiation in 3T3-L1 and MEF cells as visualized in Figure 1 (color coding according to legend at the top, only gene ontology
terms with adjusted p < 0.05 were considered) is shown.
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A number of other genes annotated as Riken clones (like
5730469M10Rik and F630110N24Rik) included in cluster
F show noticeable binding by Pparg in 3T3-L1 cells in
the first intron and hence might be interesting targets in
follow-up experimental studies. Additional target genes
were Acadm, Adcy5, Dgat1, Etfb, Ech1, Hmox1, Mdh1,
Mgst3, Pparg, Pla2g15, Phldb1, Sorbs1, and Srebf1 as
indicated in both chromatin immunoprecipitation
(ChIP) studies [42,43] of Pparg binding at the same geno-
mic region near TSS (< 1 kb) or in an intron (peak
Figure 3 In silico promoter analysis and genomic organization. (A) Statistically overrepresented (p < 0.05) potential transcription factor
binding sites (TFBS) identified by in silico analysis of genomic regions from -3 kb to + 2 kb around transcription start sites of genes with
increasing gene expression at late stages of adipocyte differentiation (cluster F) using position frequency (weight) matrices from TRANSFAC and
JASPAR. Corresponding sequence logos are shown and number of targets within the dataset (cluster) is given and tested against the number of
targets from all RefSeq transcripts using Fishers exact test. Note only transcription factor motifs are considered which are exclusively
overrepresented in cluster F. (B) The genomic organization around Foxo1 using the UCSC genome browser (NCBI37/mm9) with high similarity
to the Pparg-Rxra DR-1 motif (similarity score > 0.90) (blue ‘+’ strand, red ‘-’strand), Pparg binding regions as identified by previous studies at day
6 [42] (dark red) and day 10 [43] (orange) of 3T3-L1 adipocyte differentiation.
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height > 70) (see additional website http://icbi.at/adipo).
There was also supporting evidence of overrepresented
known cell cycle related transcription factor binding sites
in the genes of cluster B, C, and E (including NF-Y, E2F,
cMyc:Max, USF, c-ETS). In cluster A exclusively overre-
presented transcription factor binding sites includes
STAT3, STAT5A, STAT5B, MEF-2, Hand1:E47, and NF-
1. The genes encoding for STAT3 and NF-I could also
be found in this cluster, indicating that these two tran-
scription factors share similar expression profiles as their
target genes in cluster A.
Transcriptional program of Rb-/- MEFs
Recent studies showed that the retinoblastoma protein
(pRb) was expressed in the cell cycle and late cellular
differentiation phase during adipogenesis. The interest-
ing Rb1 gene expression profiles during 3T3-L1 and
wild-type MEF adipogenesis are also shown in Addi-
tional file1. Consequently, we studied the effect of per-
turbation of the MEF adipogenesis system by lack of
Rb1 by a direct comparison of the global expression
levels of Rb-/- MEF (ME3) cells to those of the wild-
type MEFs (MEFA) at 3 time points (d1, d3, d8) during
adipocyte differentiation in relation to the expression at
day 0, immediately before hormonal induction using
again whole genome cDNA microarrays (> 27k ele-
ments). Since Rb-/- MEFs do not differentiate into adi-
pocytes in response to a standard adipogenic cocktail,
the proadipogenic Pparg agonist Rosiglitazone was
added in both the Rb-/- MEF (ME3) and the Rb+/+
MEF (MEFA) differentiation experiments. We calculated
several distance measures (sum of differences, Manhat-
tan distance, Euclidean distance, and Pearson correla-
tion) between the expression profiles of ME3 and MEFA
cells for 3118 differentially expressed ESTs (Additional
file 4) and focused on 64 upregulated genes (sum of dif-
ferences > 4) and 90 downregulated genes (sum of dif-
ferences < -4). For clarity, gene expression levels of only
the most deregulated ESTs were visualized as heatmap
in Figure 4 (23 ESTs with sum of differences > 5 and 41
ESTs with sum of differences < -5).
As evident from previous studies, microarray and qPCR
analysis revealed that Ucp1, Ppargc1a, Prdm16, and
Cidea are highly upregulated in Rb-/- MEF (ME3) adi-
pocyte differentiation compared to Rb+/+ MEF (MEFA)
adipocyte differentiation (see [14,16,45], Additional file
2, and Additional file 4). Gene ontology analysis from
the 64 deregulated genes corroborated the brown(-like)
adipocyte phenotype of the Rb-/- MEF model: the most
significant overrepresented gene ontology term was
‘generation of precursor metabolites and energy’ (FDR =
3.1E-05) (including electron transferring flavoprotein,
alpha polypeptide (Etfa) and NADH dehydrogenase (ubi-
quinone) Fe-S protein 1 (Ndufs1) also involved in
oxidative phosphorylation a prominent process in brown
adipose tissue). Analysis with the tool ClueGO (Figure
5) showed prominent gene ontology terms ‘mitochon-
drion organization’, ‘electron transport’, ‘triglyceride
metabolic processes’, and ‘apoptosis’. These are related
to hallmarks of a brown adipocyte phenotype such as
mitochondrial biogenesis, metabolic processes, electron
transport, oxidative phosphorylation, and uncoupling.
Many of the activated genes are encoding for enzymes
involved in glucose or lipid metabolism and one gene
for a transcription factor (Myc).
It is noteworthy that gene set enrichment analyses of
the ranked gene list with gene sets from brown adipose
tissue versus white adipose tissue [46] and brown and
white preadipocytes at the differentiating stages [47]
showed a high enrichment score at least to the first
gene set supporting the notion that Rb is involved in
the switch between the white and brown adipocyte dif-
ferentiation process but also indicated expression phe-
notypic differences between brown adipocytes and
differentiated Rb-/- MEFs (Additional file 5). These
results suggest a different and/or additional role of pRb.
We have seen that Rb-/- MEFs behave more like pri-
mary cells from inguinal white adipose tissue than clas-
sic brown adipose tissue [48]. It was also shown that
pRb could have a different role as it might be involved
in the lineage commitment to either osteogenic or adi-
pogenic differentiation of mesenchymal stem cells [18].
Conclusion
In this work we studied adipocyte differentiation of
wild-type MEFs and Rb-/- MEFs into mature adipocytes
using microarrays and comprehensive bioinformatics
analyses. We identified novel candidates involved in
early adipogenesis as well as high-confidence genes tar-
geted by Pparg. Our findings corroborate the brown-like
phenotype of the Rb-/- MEFs. Based on the analyses we
also propose the existence of a feed-back loop between
Pparg and Foxo1 adding a novel facet to the regulatory
network orchestrating adipocyte differentiation.
The data and the analysis provide a starting point for
further experimental studies to identify target genes for
pharmacological intervention and ultimately remodeling
of white adipose tissue into brown adipose tissue.
Materials and methods
Adipocyte differentiation of wild-type (Rb+/+) and Rb-/-
mouse embryonic fibroblasts
Generation of Rb-/-MEFs and wild-type MEFs were pre-
viously performed at the Division of Cancer Biology,
Danish Cancer Society, Copenhagen, DK and described
in [49]; detailed information on the origin of these cells
and disruption of the Rb-1 gene in mice can be found
in [50]. A batch of the Rb-/- and Rb+/+ MEFs were
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kindly provided by Jiri Lukas as already used in other
studies (e.g. [14]). No animals or human subjects were
directly involved in the current study that would make
ethical approval and consent required. Wild-type mouse
embryo fibroblasts (MEFs) were differentiated at the
Department of Biochemistry and Molecular Biology,
University of Southern Denmark, Odense, DK according
to the protocol described in [13]. Briefly, cells were
induced to differentiation by the MDI protocol (1 μM
dexamethasone (DEX), 0.5 mM isobutyl methylxanthine
(MIX), and 5 μg/ml insulin). DEX and MIX were
omitted after day 2, but insulin was added throughout
Figure 4 Gene expression profiles in Rb-/- MEFs. Gene expression levels (log2-fold change) shown as heatmap for samples from 3 different
time points (d1, d3, d8) related to d0 immediately before hormonal induction of Rb-/- MEF (ME3) and Rb+/+ MEF (MEFA) differentiation. Only
genes with sum of differences > 5 or sum of differences < -5 are shown.
Hakim-Weber et al. BMC Research Notes 2011, 4:157
http://www.biomedcentral.com/1756-0500/4/157
Page 8 of 13
the differentiation. Cells were passaged and differen-
tiated in AmnioMax (Gibco) supplemented with 7,5%
fetal bovine serum. Nutrition media were changed every
second day. Rb-/- MEFs and wild-type MEFs (Rb+/+)
for comparison were differentiated using the identical
protocol, but adding Pparg ligand BRL49653 (0.5 μM) to
the induction cocktail throughout the whole differentia-
tion process. All differentiation experiments were per-
formed in triplicate. Cells were harvested and total RNA
was isolated at the preconfluent stage and at seven time
points after induction (0, 1, 2, 3, 4, 6, and 10 days) with
TRIzol reagent (Invitrogen). For the Rb-/- and Rb+/+
MEF differentiation, cells were harvested immediately
before (reference) and at three time points (1, 3, and 8
days) after induction. For each independent experiment
RNA was pooled from three different culture dishes for
each time point and from twenty dishes for each
reference. The quality of the RNA was checked using
Agilent 2100 Bioanalyzer RNA assays (Agilent Technol-
ogies) by inspection of the 28S and 18S ribosomal RNA
intensity peaks.
Gene expression and data analysis
The mouse cDNA microarrays and the hybridization
protocols used have been described previously [2].
Briefly, the spotted microarrays contain 27,000 elements
with mouse cDNA clones representing 16,000 different
genes (UniGene clusters). 10-25 micrograms (dependent
on replicated experiment) of total RNA from each time
point was reverse transcribed into cDNA, which was
then indirectly labeled with Cy5 and Cy3, respectively.
To account for technical variation, procedures were
repeated using the same samples with reversed dye
assignment. The microarrays were pre-hybridized with
Figure 5 ClueGO analysis [57]of 64 genes upregulated during Rb-/- MEF adipocyte differentiation in comparison to Rb+/+ MEF
adipocyte differentiation (sum of differences of log2-fold change > 4). Nodes (circles) represent gene ontology terms. Connections
between two nodes (edges) indicate that two gene ontology terms share genes from the considered dataset (agreement measure kappa ≥ 0.3).
The calculated kappa score is also used for defining functional groups, which are indicated by the same color. The most prominent gene
ontology term for each group (theme) is highlighted: mitochondrion organization (red), electron transport (blue), triglyceride metabolic process
(green), apoptosis (orange).
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5× SSC, 0.1% SDS,1% BSA. Pair-wise labeled cDNA
samples were combined and 20 μg of mouse Cot1 DNA
and 20 μg of poly(A) DNA were added. The mixture
was hybridized onto the slides overnight at 42°C. Fol-
lowing washing, slides were scanned with a GenePix
4000B microarray scanner (Axon Instruments) at 10 μm
resolution. The resulting TIFF images were analyzed
with GenePix Pro 4.1 software (Axon Instruments). Fea-
tures were filtered for low-quality spots. Following sub-
traction of the local background, the arrays were global
median and dye-swap normalized using ArrayNorm [51]
and the resulting ratios log2 transformed. All experi-
mental parameters, raw data, and transformed data were
uploaded to the microarray database MARS [52] and
submitted via MAGE-ML export to a public repository
(ArrayExpress [53], Accession Nos. E-MARS-12/E-
MARS-13 and A-MARS-7). After outliers were removed
the median expression values of replicated ESTs on the
microarray were calculated. Only ESTs with z > 1.5 and
significant replication (p < 0.05) in at least one time
point using the z test and implying standard normal dis-
tribution were considered differentially expressed and
used for further analysis [54,55]. Expression values and z
scores for differentially expressed ESTs were averaged
over biological replicates and annotated using the
RefSeq database (MegaBLAST E-value < 1E-30) and
Entrez Gene database. Expression profiles for MEF data
and 3T3-L1 data [2] were combined based on the same
EST ID and profiles were grouped into 6 clusters by k-
means clustering and validated by principal component
analysis. Gene ontology term overrepresentation analysis
for the different gene sets (clusters) were performed
using Fisher exact test and p-values were adjusted for
multiple hypothesis tests based on the Benjamini-Hoch-
berg method (http://genome.tugraz.at/ORA). Several dis-
tance measures between the expression profiles of the
Rb-/- MEF (ME3) and Rb+/+ MEF (MEFA) differentia-
tion models (sum of differences, Manhattan distance,
Euclidean distance, Pearson correlation coefficient) were
calculated. Over-represented gene ontology (GO) terms
for up- (sum of differences > 4) or downregulated (sum
of differences < -4) genes were identified using DAVID
[56] based on gene symbols. Up-regulated genes were
functionally grouped into gene ontology networks using
the Cytoscape plug-in ClueGO [57]. All calculations
were implemented in PERL 5.8.0 or R 2.10.1, cluster
analyses and visualizations were performed using Gen-
esis [58]. Gene set enrichment analysis (GSEA) [59] was
performed using a tool from http://www.broadinstitute.
org/gsea.
qPCR analysis
Microarray expression results were confirmed with
qPCR. cDNA was synthesized from 1.25 μg total RNA
in 20 μl using random hexamers and SuperScript II
reverse transcriptase (Invitrogen). The design of LUX™
primers was done using the Invitrogen web service.
Quantitative RT-PCR analyses were performed starting
with 12 ng reverse transcribed total RNA, with 0.5× Pla-
tinum Quantitative PCR SuperMix-UDG (Invitrogen),
with a ROX reference dye, and with a 200 nM concen-
tration of both LUX™ labeled sense and antisense pri-
mers (Invitrogen) in a 25 μl reaction. Ribosomal 18S
RNA amplifications were used to account for variability
in the initial quantities of cDNA. The relative quantifi-
cation with respect to the calibrator (preconfluent stage)
was determined using the ΔΔCt method and compared
with the normalized ratios resulting from microarray
experiments. To better characterize Rb-/- MEF (ME3)
and Rb+/+ MEF (MEFA) cells, triplicate-qPCR analyses
were performed with 4.5 ng cDNA, 200 nM primer, and
Platinum SYBR green mastermix (Invitrogen). Data were
analyzed using a real-time PCR management and analy-
sis system [60]. Values were normalized to Uxt, Ct
values and PCR efficiencies were derived as in [61].
All qPCR analyses were performed on an ABI PRISM
7000 detection system (Applied Biosystems). Primer
sequences can be found in Additional file 2.
In silico analysis of transcription factor binding sites
Statistically overrepresented (p < 0.05) potential tran-
scription factor binding sites (TFBS) were identified by
in silico analysis of genomic regions from -3 kb to + 2
kb around transcription start sites of genes within each
cluster and all RefSeq transcripts using known (TRANS-
FAC [62], JASPAR [63]), and newly compiled position
frequency (weight) matrices (http://genome.tugraz.at/
Logo). Potential binding sites were identified if the simi-
larity score for each PWM was equal or above the
threshold (allowing 1 binding site with 10kb of mouse
coding sequences) based on an implementation of the
MatInspector algorithm [64]. The number of targets
(showing at least one TFBS) within the gene set (cluster)
was tested against the number of targets from all RefSeq
transcripts using Fishers exact test and p-value was
adjusted for multiple hypothesis testing based on the
false discovery rate according to the method of Benja-
mini-Hochberg [65]. Genome organization around genes
(genomic region from 20 kb upstream of transcription
start to 20 kb downstream of transcription end) showing
similar expression profile as Pparg were constructed
using UCSC genome browser (NCBI37/mm9), custom
track data from chromatin immune precipitation
followed by sequencing at day 6 [42] or microarray ana-
lysis at day 10 [43] during 3T3-L1 adipocyte differentia-
tion, and Pparg-Rxra direct repeats 1 (DR1) motifs
(similarity score > 0.90) (see additional website http://
icbi.at/adipo).
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Additional material
Additional file 1: Gene expression levels (log2-fold change) of 1579
in 6 cluster grouped ESTs at several time points during adipocyte
differentiation of MEFs and 3T3-L1 cells (as visualized in Figure 3).
ESTs were annotated according to the mouse RefSeq database (NCBI
MegaBLAST E-value < 1E-30) and Entrez Gene database. Unique genes
within each cluster were identified and overrepresented gene ontology
(GO) terms are provided.
Additional file 2: Results and primer sequences from q-RT-PCR
analysis for validation of microarray experiments and to identify
expression levels for specific genes during ME3 and MEFA
differentiation.
Additional file 3: Statistically overrepresented (p < 0.05) potential
transcription factor binding sites (TFBS) identified by in silico
analysis of genomic regions from -3 kb to + 2 kb around
transcription start sites of genes with increasing gene expression at
late stages of adipocyte differentiation (cluster F) using position
frequency (weight) matrices from TRANSFAC and JASPAR.
Corresponding sequence logos from http://genome.tugraz.at/Logo are
shown and number of targets within the dataset (cluster) is given and
tested against the number of targets from all RefSeq transcripts using
Fishers exact test. Note only transcription factor motifs are considered
which are exclusively overrepresented in cluster F.
Additional file 4: Gene expression levels (log2-fold change) of 3118
ESTs for samples from 3 different time points (d1, d3, d8) related
to d0 immediately before hormonal induction of Rb-/- MEF (ME3)
and Rb+/+ MEF (MEFA) differentiation. Several distance measures
between the expression profiles of the two cell differentiation models
(sum of differences, Manhattan distance, Euclidean distance, Pearson
correlation coefficient) are provided. Unique genes upregulated (sum of
differences > 4) and downregulated (sum of differences < -4) in the ME3
cell differentiation model compared to the MEFA differentiation are
emphasized and overrepresented gene ontology (GO) terms are
provided.
Additional file 5: Gene set enrichment analysis of the gene list from
comparison of Rb-/- MEFs and Rb+/+ MEFs during adipocyte
differentiation ranked by sum of differences in a gene set of
significantly upregulated (log2-fold change > 2) genes in brown
adipose tissue versus white adipose tissue [46]and in a gene set
with significantly upregulated (log2-fold change > 1) genes in
brown versus white preadipocytes at the differentiating stages [47].
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